Alembic Pharmaceuticals has informed that a Meeting of Board of Directors of the Company will be held on Tuesday, 4th November 2025 to consider and approve Unaudited Financial Results of the Company for the quarter and half year ended 30th September, 2025. Pursuant to the Company’s Code of Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons and their Immediate Relatives, the trading window for dealing in securities of the Company which was closed from 1st October, 2025, will re-open 48 hours after the declaration of the financial results.
The above information is a part of company’s filings submitted to BSE.
